Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease

Sci Rep. 2019 Feb 14;9(1):2121. doi: 10.1038/s41598-019-39202-5.

Abstract

Cardiovascular disease (CVD) is a lifestyle-related disease (LSRD) and one of the largest public health issues. Risk factors for CVD correlate with an excessive intake of glucose and/or fructose, which has been shown to induce the production of advanced glycation end-products (AGEs). We previously identified AGEs derived from glyceraldehyde and named them toxic AGEs (TAGE) due to their cytotoxicities and relationship with LSRD. We also reported that extracellular TAGE in the vascular system may promote CVD and that serum TAGE levels are associated with risk factors for CVD. The mechanisms responsible for the onset and/or progression of CVD by extracellular TAGE or the above risk factors involve vascular disorders. In the present study, we revealed that rat primary cultured cardiomyocytes generated intracellular TAGE, which decreased beating rates and induced cell death. LC3-II/LC3-I, a factor of autophagy, also decreased. Although intracellular TAGE may be targets of degradation as cytotoxic proteins via autophagy, they may inhibit autophagy. Furthermore, the mechanisms by which intracellular TAGE decrease beating rates and induce cell death may involve the suppression of autophagy. The present results suggest that intracellular TAGE are generated in cardiomyocytes and directly damage them, resulting in CVD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Autophagy
  • Cardiovascular Diseases / chemically induced*
  • Cardiovascular Diseases / pathology
  • Disease Progression
  • Glycation End Products, Advanced / toxicity*
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / pathology*
  • Rats
  • Rats, Wistar

Substances

  • Glycation End Products, Advanced